Macular degeneration and Glaucoma
Summary:
Glaucoma is found among people with Macular degeneration, especially for people who are female, 60+ old.
The study analyzes which people have Glaucoma with Macular degeneration. It is created by eHealthMe based on reports of 80 people who have Macular degeneration from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Macular degeneration?
Macular degeneration (painless eye condition that leads to the gradual loss of central vision) is found to be associated with 866 drugs and 1,486 conditions by eHealthMe. Check the latest studies of Macular degeneration.
What is Glaucoma?
Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 1,237 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Glaucoma.
80 people who have Macular Degeneration and Glaucoma are studied.

Gender of people who have Macular Degeneration and experienced Glaucoma *:
- female: 67.53 %
- male: 32.47 %
Age of people who have Macular Degeneration and experienced Glaucoma *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 5.5600000000000005 %
- 60+: 94.44 %
Common co-existing conditions for these people *:
- Polymyalgia Rheumatica (pain in many muscles): 13 people, 16.25%
- Asthma: 11 people, 13.75%
- Stress And Anxiety: 4 people, 5.00%
- Thyroid Diseases: 3 people, 3.75%
- Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 3.75%
- High Blood Pressure: 3 people, 3.75%
- Osteoporosis (bones weak and more likely to break): 3 people, 3.75%
- High Blood Cholesterol: 3 people, 3.75%
- Stable Angina (a constant chest pain): 3 people, 3.75%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 2.50%
Common drugs taken by these people *:
- Lucentis: 23 people, 28.75%
- Latanoprost: 14 people, 17.50%
- Synthroid: 14 people, 17.50%
- Actemra: 13 people, 16.25%
- Prednisone: 12 people, 15.00%
- Advair Hfa: 11 people, 13.75%
- Memantine: 11 people, 13.75%
- Brimonidine Tartrate: 11 people, 13.75%
- Namenda Xr: 11 people, 13.75%
- Proair Hfa: 11 people, 13.75%
Common symptoms for these people *:
- Visual Acuity Reduced (reduced clearness of vision): 19 people, 23.75%
- Blindness: 17 people, 21.25%
- Nasopharyngitis (inflammation of the nasopharynx): 13 people, 16.25%
- Body Height Decreased: 12 people, 15.00%
- Rhinorrhea (watery mucus discharge from the nose): 11 people, 13.75%
- Hoarseness Or Changing Voice: 11 people, 13.75%
- Neuropathy Peripheral (surface nerve damage): 11 people, 13.75%
- Lower Respiratory Tract Infection: 11 people, 13.75%
- Laryngeal Nerve Damage: 11 people, 13.75%
- Intraocular Pressure Increased: 11 people, 13.75%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Glaucoma?
- Check whether Glaucoma is associated with a drug or a conditionRelated publications that referenced our studies
- Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
- Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Related studies:
Treatments, associated drugs and conditions:
- Macular degeneration (25,571 reports)
- Glaucoma (61,926 reports)
All the drugs that are associated with Glaucoma:
- Glaucoma (1,237 drugs)
All the conditions that are associated with Glaucoma:
- Glaucoma (1,653 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Glaucoma and Macular degeneration, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Albuterol cause Nasal Mucosal Disorder? - a second ago
- Could Aripiprazole cause Analgesic Drug Level Above Therapeutic? - 4 seconds ago
- Drug interactions of Phentermine Hydrochloride and Proair Hfa - 8 seconds ago
- Could Norflex cause Micturition Urgency? - 33 seconds ago
- Drug interactions of Venlafaxine Hydrochloride and Fentanyl - 39 seconds ago
- Could Forteo cause Bone Fissure? - 44 seconds ago
- How effective is Spironolactone for Acne? - 47 seconds ago
- Could Lexapro cause Colitis Ulcerative Aggravated? - 47 seconds ago
- Drug interactions of Fluoxetine and Metronidazole - 50 seconds ago
- Drug interactions of Pepcid Ac and Oxcarbazepine - 53 seconds ago